Menu

Duesburg Appeals

The article titled 230 Publication Of AIDS Article Spurs Debate Over Peer Review” (The Scientist, April 3, 1989, page 1), described the scrutiny that my thesis—that HIV is not the cause of AIDS— was subjected to prior to its publication in PNAS (86:755-64, 1989). This report was accurate, fair, and open. However, I was disappointed to read that retrovirologists Howard Temin and Harold Ginsberg stated to The Scientist that my article “still contained errors,” despite

Oct 16, 1989
Peter Duesberg

The article titled 230 Publication Of AIDS Article Spurs Debate Over Peer Review” (The Scientist, April 3, 1989, page 1), described the scrutiny that my thesis—that HIV is not the cause of AIDS— was subjected to prior to its publication in PNAS (86:755-64, 1989). This report was accurate, fair, and open. However, I was disappointed to read that retrovirologists Howard Temin and Harold Ginsberg stated to The Scientist that my article “still contained errors,” despite seven reviews, including three anonymous ones. Since I like nothing more than to correct my own errors—particularly when they concern such an important subject as AIDS—I have written to both Temin and Ginsberg, asking them to please identify these errors. Temin responded to the two letters I sent him by saying he had no time to identify these errors, and Ginsberg did not reply at all. I herein repeat my request that Temin and Ginsberg substantiate their claims that my published PNAS paper still contained errors.

PETER DUESBERG
Department of Molecular Biology
University of California
Berkeley, Calif.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.